Sarepta Therapeutics Other Non-Current Liabilities 2010-2024 | SRPT

Sarepta Therapeutics other non-current liabilities for the quarter ending September 30, 2024 were $0.048B, a 27.03% increase year-over-year.

  • Sarepta Therapeutics other non-current liabilities for 2023 were $0.041B, a 11.26% increase from 2022.
  • Sarepta Therapeutics other non-current liabilities for 2022 were $0.037B, a 32.34% decline from 2021.
  • Sarepta Therapeutics other non-current liabilities for 2021 were $0.055B, a 22.65% decline from 2020.

Sarepta Therapeutics Other Non-Current Liabilities 2010-2024 | SRPT

  • Sarepta Therapeutics other non-current liabilities for 2023 were $0.041B, a 11.26% increase from 2022.
  • Sarepta Therapeutics other non-current liabilities for 2022 were $0.037B, a 32.34% decline from 2021.
  • Sarepta Therapeutics other non-current liabilities for 2021 were $0.055B, a 22.65% decline from 2020.